That's interesting archive
The first-ever New Zealand COPD guidelines have been published. Developed by the Asthma and Respiratory Foundation and led by Dr Stuart Jones and Professor Bob Hancox, these guidelines clearly lay out the recommendations for assessment and management of COPD.
Joanna Hikaka, Rhys Jones, Carmel Hughes, Matin J. Connolly and Nataly Martini. Drugs & Aging. Online ahead of print. January 2021.
This review from the University of Auckland examines ethnic variation in the quality use of medicines between Māori and non-Māori older adult populations in NZ. It identifies that inequities in quality medicines use exist and provides a starting point to develop pro-equity solutions.
The Tongan Health Society is working on an innovative approach to underpin best practice models for patients with diabetes who are on maximum oral hypoglycaemic medication to start insulin therapy when they are hesitant to do so.
This article answers some of the frequently asked questions about the newly funded type 2 diabetes medicine - empagliflozin (with and without metformin) and dulaglutide, which is to be funded as soon a possible following Medsafe approval.
On 21 December 2020 PHARMAC approved funding for two new medicines with substantial health benefits for around 53,000 New Zealanders with type 2 diabetes.
The Asthma and Respiratory Foundation has just launched its new online store, where you can find free asthma and COPD resources and guidelines.
This article from RNZ summarises the findings from a recent study by the University of Waikato. The study found that Māori patients receive fewer prescriptions for metformin than non-Māori, despite suffering from the disease at twice the rate.
Lynne Chepulis, Christopher Mayo, Brittany Morison, Rawiri Keenan, Chunhuan Lao, Ryan Paul and Ross Lawrenson. Journal of Primary Health Care 12(4). November 2020.
This study from the University of Waikato investigated metformin adherence among New Zealand patients. Prescription and dispensing data was used in the analysis and the study found that ethnic disparity exists for metformin prescribing, leading to an overall reduction in metformin treatment for Māori patients.
Final Report. Shirley Simmonds, Marnie Carter, Nick Preval and Ross Wilson. Medical Council of New Zealand, and Te Ohu Rata O Aotearoa (Te ORA). 17 September 2020.
This independent report outlines findings of the current state of cultural safety and health equity delivered by doctors practising in Aotearoa New Zealand and experienced by patients and whānau. Māori patients’ experiences are the focus of the report, however many of the challenges and solutions will be applicable to other ethnic groups and populations who experience inequitable healthcare.
Elana Curtis, Rhys Jones, David Tipene-Leach, Curtis Walker, Belinda Loring, Sarah-Jane Paine and Papaarangi Reid. International Journal for Equity in Health (2019)18:174.